Identification of a cytisine-based EED-EZH2 protein-protein interaction inhibitor preventing metastasis in triple-negative breast cancer cells
Enhancer of zeste homolog 2 (EZH2) is activated in breast cancer, particularly in triple-negative breast cancer (TNBC), and is critical for cell invasion. It interacts with embryonic ectoderm development (EED) in maintaining cancer stem cells (CSC) and epithelial-mesenchymal transition (EMT) propert...
Saved in:
Main Authors: | Shasha Cheng (Author), Guan-Jun Yang (Author), Wanhe Wang (Author), Ying-Qi Song (Author), Chung-Nga Ko (Author), Quanbin Han (Author), Dik-Lung Ma (Author), Chung-Hang Leung (Author) |
---|---|
Format: | Book |
Published: |
Compuscript Ltd,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of the CDK9-cyclin T1 protein-protein interaction as a new approach against triple-negative breast cancer
by: Sha-Sha Cheng, et al.
Published: (2022) -
Dehydroeburicoic Acid, a Dual Inhibitor against Oxidative Stress in Alcoholic Liver Disease
by: Shasha Cheng, et al.
Published: (2022) -
Brain Metastasis in Triple-Negative Breast Cancer
by: Eduarda Bustamante, et al.
Published: (2024) -
Computational strategies for PROTAC drug discovery
by: Jia Wu, et al.
Published: (2023) -
CBX2 and EZH2 cooperatively promote the growth and metastasis of lung adenocarcinoma
by: Fei-Fei Hu, et al.
Published: (2022)